A A A

Current review panels

Review panels are composed for specific competitions and membership will depend on the expertise needed. Please select the appropriate competition for current information on panel composition.

Note:

For competitions with an LOI stage - panels may be reduced between stages depending on expertise required to review the full applications. Panel members participating in the LOI review only will be marked with an *.

For competitions with multiple panels – applicants indicate their panel recommendation, however, final panel selection will be determined by the panel chairs and CCS based on the panel with the most appropriate expertise.

Innovation Grant and Innovation to Impact Grant panels

I1a - Biomarkers and Genomics

Including genomics, proteomics, metabolomics (and other ‘omics’), high-throughput sequencing, bioinformatics, diagnostic, prognostic and predictive biomarkers, circulating tumour cells.

Panel meeting: December 5, 2016

Harriet Feilotter, PhD (Chair) Queen’s University
Kingston, ON
Jane Bayani, PhD Ontario Institute for Cancer Research
Toronto, ON
Nicolas Crapoulet, PhD
Atlantic Cancer Research Institute
Moncton, NB
Andrew Emili, PhD
University of Toronto
Toronto, ON 
Michael Hendzel, PhD  University of Alberta
Edmonton, AB
Thomas Kislinger, PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
Julian Lum, PhD  BC Cancer Agency
Vancouver, BC
Leigh Murphy, PhD
Manitoba Institute of Cell Biology
Winnipeg, MB
Kirill Rosen, PhD Dalhousie University
Halifax, NS
Robert Sladek, MD McGill University
Montreal, QC
Zhaolin Xu, MD Dalhousie University
Halifax, NS
Gelareh Zadeh, MD/PhD The Toronto Hospital (Western Division) - UHN
Toronto, ON
Hansen He, PhD (Scientific Officer) Princess Margaret Cancer Centre - UHN
Toronto, ON 
Scott Bratman, MD/PhD (Scientific Officer) Princess Margaret Cancer Centre - UHN
Toronto, ON
Tanya Gallant (Community Representative) Canadian Cancer Society - PEI Division 
Mai Tran (Community Representative)  Canadian Cancer Society - Alberta/NWT Division

 

I1b - Gene Regulation & Cell Biology

Including mechanisms of transcriptional control, epigenetics, chromatin structure and function, translational control, RNA biology, post-translational modifications, telomere function, DNA damage and repair, organellar biology, model organisms, angiogenesis, cell migration, cell invasion, tumour environment.

Panel meeting: December 8, 2016

Peter Greer, PhD (Chair) Queen's University
Kingston, ON
Kristin Baetz, PhD University of Ottawa
Ottawa, ON
Peter Black, MD University of British Columbia
Vancouver, BC
David Brindley, PhD University of Alberta
Edmonton, AB
Elizabeth Conibear, PhD
University of British Columbia
Vancouver, BC
Richard Fahlman, PhD University of Alberta
Edmonton, AB
Gerardo Ferbeyre, PhD University of Montreal
Montreal, QC
Imed Gallouzi, PhD
McGill University
Montreal, QC 
Anne-Claude Gringas, PhD
Mount Sinai Hospital
Toronto, ON 
Benjamin Kwok, PhD Institute for Research in Immunology and Cancer (IRIC)
Montreal, QC
Mathieu Lupien, PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
Jane McGlade, PhD The Hospital for Sick Children
Toronto, ON
Gilbert Prive, PhD
University Health Network
Toronto, ON
Uri Tabori, MD The Hospital for Sick Children
Toronto, ON 
Yojiro Yamanaka, PhD McGill University
Montreal, QC
Michael Downey, PhD (Scientific Officer) University of Ottawa
Ottawa, ON 
Paul Kongkham, MD/PhD (Scientific Officer) University Health Network
Toronto, ON
Dawn Ashforth (Community Representative) Canadian Cancer Society - Ontario Division 
John Sterns (Community Representative)  Canadian Cancer Society - Ontario Division

 

I2 - Imaging and Technology Development

Including platform and tool development, systems biology, magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound, computer tomography (CT), radiobiology, radiotherapy, photodynamic therapy (PDT), optical imaging, microfluidics, nanotechnology.

Panel meeting: December 12, 2016

Aaron Fenster, PhD (Chair) Robarts Research Institute
London, ON
David Juncker, PhD McGill University
Montreal, QC 
Marianna Koritzinsky, PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
Piotr Kozlowski, PhD
University of British Columbia
Vancouver, BC
Jonathan Lovell, PhD University at Buffalo
Buffalo, NY
Cynthia Menard, MD Centre Hospitalier de l’Universite de Montreal
Montreal, QC
Alan Nichol, MD BC Cancer Agency
Vancouver, BC 
Mark Niedre, PhD Northeastern University
Boston, MA
Christopher Phenix, PhD
University of Saskatoon
Saskatoon, SK
Paul Schaffer, PhD TRIUMF
Vancouver, BC
Shiladitya Sengupta, PhD Brigham and Women's Hospital
Cambridge, MA
Jack Tuszynski, PhD University of Alberta
Edmonton, AB
Kazuhiro Yasufuku, MD/PhD
Toronto General Hospital - UHN
Toronto, ON 
Haishan Zeng, PhD BC Cancer Agency
Vancouver, BC
Gang Zheng, PhD
Princess Margaret Cancer Centre - UHN
Toronto, ON
Christopher Moraes, PhD (Scientific Officer) McGill University
Montreal, QC 
Aaron Ward, PhD (Scientific Officer) London Health Sciences Centre
London, ON 
Sean Nurmsoo (Community Representative)  Canadian Cancer Society - Nova Scotia Division
Yalda Hazrat (Community Representative) Canadian Cancer Society - BC/Yukon Division 

 

I3 - Immunology, Signalling and Stem Cells

Including metastasis, hormone-sensitive pathways, growth-factor mediated signalling, immunotherapies, viral therapeutics, cancer stem cells, signal transduction, innate immunity and infection, tumour antigens, immune surveillance, hematopoiesis.

Panel meeting: December 9, 2016

Jayne Danska, PhD (Chair) The Hospital for Sick Children
Toronto, ON
Ninan Abraham, PhD University of British Columbia
Vancouver, BC
David Brooks, PhD
Princess Margaret Cancer Centre - UHN
Toronto, ON 
David Evans, PhD University of Alberta
Edmonton, AB
Spencer Gibson, PhD
University of Manitoba
Winnipeg, MB
Michael Gold, PhD
University of British Columbia
Vancouver, BC
Norman Iscove, MD/PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
Kevin Kane, PhD University of Alberta
Edmonton, AB 
Jean Marshall, PhD Dalhousie University
Halifax, NS
Mark Minden, MD/PhD  Princess Margaret Cancer Centre - UHN
Toronto, ON
Luc Sabourin, PhD Ottawa Hospital Research Institute
Ottawa, ON
Vuk Stambolic, PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
William Stanford, PhD Ottawa Hospital Research Institute
Ottawa, ON
David Stojdl, PhD Children's Hospital of Eastern Ontario
Ottawa, ON 
Jacques Thibodeau, PhD  University of Montreal
Montreal, QC 
Patrick O’Donoghue, PhD (Scientific Officer) Western University
London, ON
Jean Wang, MD/PhD (Scientific Officer) Princess Margaret Cancer Centre - UHN
Toronto, ON
Sandy McDonald (Community Representative)  Canadian Cancer Society - Ontario Division 
Genevieve Roussy (Community Representative) Canadian Cancer Society - New Brunswick Division 

 

I4 - Novel Therapeutics

Including drug candidates, rational drug design, hit and target validation, compound screening, medicinal chemistry, pharmacology, drug delivery systems, drug transport, drug resistance, combination therapies and pharmacogenomics.

Panel meeting: December 1, 2016

Craig Thomas, PhD (Chair) National Institutes of Health
Rockville, MD
Philippe Bedard, MD Princess Margaret Cancer Centre - UHN
Toronto, ON
Robert Britton, PhD Simon Fraser University
Burnaby, BC
Daniel De Carvalho, PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
Mark Glover, PhD University of Alberta
Edmonton, AB
Matthew Hall, PhD National Institutes of Health
Rockville, MD 
Philip Hieter, PhD University of British Columbia
Vancouver, BC
Jose Monzon, MD/PhD Tom Baker Cancer Centre
Calgary, AB
Kevin Petrecca, MD/PhD  McGill University
Montreal, QC 
Lynne-Marie Postovit, PhD  University of Alberta
Edmonton, AB
Michel Roberge, PhD University of British Columbia
Vancouver, BC
Donna Senger, PhD University of Calgary
Calgary, AB
Christian Steidl, MD/PhD
BC Cancer Agency
Vancouver, BC 
Josie Ursini-Siegel, PhD Lady Davis Institute
Montreal, QC
Murray Webb, PhD The Centre for Drug Research and Development (CDRD)
Vancouver, BC
Jeremy Wulff, PhD University of Victoria
Victoria, BC
Rebecca Laposa, PhD (Scientific Officer) University of Toronto
Toronto, ON
Daniel Schramek, PhD (Scientific Officer) Mount Sinai Hospital
Toronto, ON
Nancy McFadden (Community Representative) Canadian Cancer Society - Ontario Division 
Angie Woodcock (Community Representative) Canadian Cancer Society - Ontario Division

 

I5 - Prevention and Quality of Life 

Including epidemiology, prevention interventions, lifestyle and environmental risk factors, health economics, health services, quality of life, survivorship, palliative care, psychosocial issues, knowledge translation and exchange.

Panel meeting: June 2, 2016

Patricia Parker, PhD (Chair) Memorial Sloan-Kettering Cancer Center
New York, NY
Catherine Alfano, PhD  American Cancer Society
Washington, DC 
Angel Aranout, MD Ottawa Hospital Research Institute
Ottawa, ON 
Lisa Barbera, MD
Sunnybrook Research Institute
Toronto, ON
Hugh Davies, PhD University of British Columbia
Vancouver, BC
Karen Kopciuk, PhD  Alberta Health Services
Calgary, AB 
Jane McCusker, MD/DrPH
McGill University
Montreal, QC
Jennifer O'Loughlin, PhD

University of Montreal
Montreal, QC

Robert Reid, PhD/MBA University of Ottawa Heart Institute
Ottawa, ON
Catherine Sabiston, PhD University of Toronto
Toronto, ON 
Jonathan Sussman, MD Juravinski Cancer Centre
Hamilton, ON
Alice Wei, MD  Princess Margaret Cancer Centre - UHN
Toronto, ON
Jennifer Brunet, PhD (Scientific Officer) University of Ottawa
Ottawa, ON
Brita Danielson, MD (Scientific Officer) Alberta Health Services
Edmonton, AB
Stephen Ng (Community Representative)  Canadian Cancer Society - BC/Yukon Division

 

Impact Grant panel

LOI review teleconference: June 29, 2017

Panel meeting: November 29, 2017

John Bell, PhD (Co-Chair) Ottawa Hospital Research Institute
Ottawa, ON 
Craig Earle, MD (Co-Chair) Sunnybrook Research Institute
Toronto, ON 
*Stephane Angers, PhD University of Toronto
Toronto, ON
*Mick Bhatia, PhD McMaster University
Hamilton, ON
*Deborah Bowen, PhD University of Washington
Seattle, WA
*Grant Brown, PhD University of Toronto
Toronto, ON
Andrew Craig, PhD Queen’s University
Kingston, ON
Shoukat Dedhar, PhD BC Cancer Agency
Vancouver, BC
*Mary Jane Esplen, PhD/RN Princess Margaret Cancer Centre – UHN
Toronto, ON
Steven Gallinger, MD Mount Sinai Hospital
Toronto, ON 
Trang Hoang, PhD IRIC
Montreal, QC
Robert Holt, PhD BC Cancer Agency
Vancouver, BC
Nada Jabado, MD/PhD McGill University
Montreal, QC
Rama Khokha, PhD  Princess Margaret Cancer Centre – UHN
Toronto, ON 
*Robert Korneluk, PhD Children’s Hospital of Eastern Ontario
Ottawa, ON
Sylvain Meloche, PhD University of Montreal
Montreal, QC
Anne-Marie Mes-Masson, PhD Centre de recherche du CHUM
Montreal, QC 
Karen Mossman, PhD McMaster University
Hamilton, ON
*Brad Nelson, PhD BC Cancer Agency
Victoria, BC 
Poul Sorensen, MD/PhD  BC Cancer Agency
Vancouver, BC 
Geoff Porter, MD (Scientific Officer)
Dalhousie University
Halifax, NS
Lillian Sung, MD/PhD (Scientific Officer) The Hospital for Sick Children
Toronto, ON
Sandy McDonald (Community Representative) Canadian Cancer Society - Ontario Division 
Rabeya Sharmin (Community Representative) Canadian Cancer Society - Ontario Division

Prevention Innovation Grant panel

Panel meeting: October 5, 2017

Christine Friedenreich, PhD (Chair)  Alberta Health Services
Calgary, AB
Michael Chaiton, PhD  University of Toronto
Toronto, ON
Andrea Cherrington, MD University of Alabama at Birmingham
Birmingham, AL
Sean Cleary, MD Mayo Clinic
Rochester, MN
Hugh Davies, PhD University of British Columbia
Vancouver, BC 
Emmanuel Guindon, PhD
McMaster University
Hamilton, ON
Julia Knight, PhD
Mount Sinai Hospital
Toronto, ON
Karen Kopciuk, PhD Alberta Health Services
Calgary, AB
Charles Matthews, PhD
National Cancer Institute
Bethesda, MD
Colleen McBride, PhD Emory University
Atlanta, GA
Lawrence Paszat, MD University of Toronto
Toronto, ON 
Mark Purdue, PhD National Cancer Institute
Bethesda, MD 
Nicolas Wentzensen, MD/PhD National Cancer Institute
Bethesda, MD 
Regina Ziegler, PhD National Cancer Institute
Bethesda, MD
Jennifer Brunet, PhD (Scientific Officer) University of Ottawa
Ottawa, ON
Gillian Hanley, PhD (Scientific Officer) University of British Columbia
Vancouver, BC 
Joel Finlay (Community Representative) Canadian Cancer Society - BC/Yukon Division
Elizabeth MacLeod (Community Representative) Canadian Cancer Society - Ontario Division

Quality of Life Grant panel

LOI review teleconference: September 12, 2017

Panel meeting: January 10, 2018

Jamie Studts, PhD (Chair) University of Kentucky
Lexington, KY
Natasha Leighl, MD (Chair) Princess Margaret Cancer Centre
Toronto, ON
Jessica Burris, PhD University of Kentucky
Lexington, KY
Kristin Campbell, PhD University of British Columbia
Vancouver, BC
Anees Chagpar, MD Yale University
New Haven, CT
Kelvin Chan, MD Sunnybrook Research Institute
Toronto, ON 
Winson Cheung, PhD BC Cancer Agency
Vancouver, BC
Kristine Donovan, PhD/MBA  Moffitt Cancer Center and Research Institute
Tampa, FL
Wendy Duggleby, PhD University of Alberta
Edmonton, AB
David Eisenstat, MD University of Alberta
Edmonton, AB 
Heidi Hamann, PhD University of Arizona
Tucson, AZ
Shelby Langer, PhD Arizona State University
Tucson, AZ 
Sophie Lebel, PhD
University of Ottawa
Ottawa, ON
Christopher Longo, PhD McMaster University
Hamilton, ON
Paul Nathan, MD
The Hospital for Sick Children
Toronto, ON
Suzanne O'Neill, PhD
Georgetown University
Washington, DC
Tony Panzarella, MSc Princess Margaret Cancer Centre
Toronto, ON 
Tara Schapmire, PhD
University of Louisville School of Medicine
Louisville, KY 
Allen Sherman, PhD University of Arkansas for Medical Sciences
Little Rock, AR
Sumit Gupta, MD/PhD (Scientific Officer)
The Hospital for Sick Children
Toronto, ON
Alexander Louie, MD (Scientific Officer)
Lawson Health Research Institute
London, ON 
Scott Johnson (Community Representative) Canadian Cancer Society - Alberta/NWT Division 
Cindy Vinall (Community Representative) Canadian Cancer Society - Ontario Division

Knowledge to Action Grant panel

Panel meeting: September 15, 2017

David Chambers, PhD (Chair)  National Cancer Institute
Rockville, MD
Smita Banerjee, PhD Memorial Sloan-Kettering Cancer Center
New York, NY 
Carole Estabrooks, RN/PhD University of Alberta
Edmonton, AB
Anna Gagliardi, PhD University Health Network
Toronto, ON 
Monika Krzyzanowska, MD Princess Margaret Cancer Centre – UHN
Toronto, ON
France Légaré, MD/PhD Laval University
Quebec City, QC
Martine Puts, RN/PhD University of Toronto
Toronto, ON
Brenda Sabo, RN/PhD Dalhousie University
Halifax, NS
Janet Squires, RN/PhD University of Ottawa
Ottawa, ON
Marko Simunovic, MD McMaster University
Hamilton, ON
Robin Urquhart, PhD Dalhousie University
Halifax, NS 
Jessie-Lee McIsaac, PhD (Scientific Officer) Dalhousie University
Halifax, NS
Stephen Ng (Community Representative) Canadian Cancer Society - BC/Yukon Division

CCS-Quebec Division/Mont Gabriel Summit Research Fund (Cole Foundation) Grant panel

The Canadian Cancer Society Research Institute is pleased to support the partnership between the CCS Quebec Division, and the Cole Foundation and its partners, to fund research grants in the area of pediatric and young adult leukemia and lymphoma research. The CCSRI will administer the competition on their behalf as per CCSRI processes. Details of the competition can be found here.

Panel meeting: June 5, 2017

Jason Berman, MD (Chair) Dalhousie University
Halifax, NS
Sarah Alexander, MD The Hospital for Sick Children
Toronto, ON
Harold Atkins, MD Ottawa Hospital Research Institute
Ottawa, ON
Jeanette Boudreau, PhD
Dalhousie University
Halifax, NS
Todd Druley, MD/PhD Washington University in St. Louis
Saint Louis, MO
Xiaoyan Jiang, MD/PhD BC Cancer Agency
Vancouver, BC
Donna Johnston, PhD Children's Hospital of Eastern Ontario
Ottawa, ON 
Mark Minden, MD/PhD Princess Margaret Cancer Centre – UHN
Toronto, ON
Aaron Schimmer, MD/PhD Princess Margaret Cancer Centre – UHN
Toronto, ON
Steven Chan, MD/PhD (Scientific Officer) University Health Network
Toronto, ON

Breast Cancer Research Grant panels

Panel I - Fundamental laboratory and pre-clinical research

Fundamental laboratory and pre-clinical investigations addressing biology of breast cancer, etiology, prevention, early detection, diagnosis, prognosis, treatment (discovery and development), and development and characterization of model systems.

LOI Review meeting: October 13, 2016

Full Application Review meeting: February 27 & 28, 2017 

Jonathan Bramson, PhD (Chair) McMaster University
Hamilton, ON
Paola Marignani, PhD (Vice Chair)
Dalhousie University
Halifax, NS
Tommy Alain, PhD* Children's Hospital of Eastern Ontario
Ottawa, ON
Nicolas Bisson, PhD
Université Laval
Québec, QC
Ann Dorward, PhD
Memorial University of Newfoundland
St. John's, NL 
Humphrey Fonge, PhD*
University of Saskatchewan
Saskatoon, SK
Leonard Foster, PhD*
University of British Columbia
Vancouver, BC
Mitsuru Futakuchi, PhD*
Nagoya City University
Nagoya, Japan
Louis Gendron, PhD*
Université de Sherbrooke
Sherbrooke, QC
Ing Swie Goping, PhD  University of Alberta
Edmonton, AB 
Kensuke Hirasawa, PhD  Memorial University of Newfoundland
St. John’s, NL 
Nagarajan Kannan, PhD  Mayo Clinic
Rochester, MN 
Thomas Klonisch, PhD  The University of Manitoba
Winnipeg, MB 
Ujendra Kumar, PhD  University of British Columbia
Vancouver, BC  
Wan Lam, PhD*  BC Cancer Agency
Vancouver, BC 
James Lim, PhD*  University of British Columbia
Vancouver, BC
Julian Lum, PhD  BC Cancer Agency
Victoria, BC 
Anthony Magliocco, MD*  L. Lee Moffitt Cancer Centre & Research Institute
Tampa, FL 
Brian Marples, PhD*  University of Miami Miller School of Medicine
Miami, FL 
Luke McCaffrey, PhD  McGill University
Montreal, QC 
David Murray, PhD  University of Alberta
Edmonton, AB 
Neil O’Brien, PhD*  University of California, Los Angeles
Los Angeles, CA 
Catherine Pallen, PhD*  University of British Columbia
Vancouver, BC 
Lawrence Pfeffer, PhD*  The University of Tennessee
Memphis, TN 
Matthew Sikora, PhD  University of Colorado
Denver, CO 
John Spinelli, PhD*  BC Cancer Agency
Vancouver, BC 
Catherine Too, PhD*  Dalhousie University
Halifax, NS 
Alan Underhill, PhD*  University of Alberta
Edmonton, AB 
Nelson Wong, PhD  BC Cancer Agency
Vancouver, BC 
Yuliang Wu, PhD*  University of Saskatchewan
Saskatoon, SK 
Donald T. Yapp, PhD*  BC Cancer Agency
Vancouver, BC 
Sheila Singh, MD/PhD (External)  McMaster University
Hamilton, ON 
Lindsay DeVorkin, PhD (Scientific Officer)  BC Cancer Agency
Victoria, BC 
* denotes reviewers who participated in the LOI Review Process only

 

Panel II - Clinical, psychosocial, and evaluative research

Clinical projects and evaluative research addressing etiology, prevention, early detection, diagnosis, prognosis, treatment (clinical applications), evaluation of delivery methods and interventions, as well as projects addressing psychosocial issues, supportive care, survivorship, quality of life, behavioural research, cancer control, health systems and outcomes research.

LOI Review meeting: October 14, 2016

Full Application Review meeting: March 1, 2017 

Stephen Chia, MD (Co-Chair) BC Cancer Agency
Vancouver, BC
Craig Earle, MD (Co-Chair)
Sunnybrook Health Sciences Centre
Toronto, ON
Samuel Aparicio, PhD BC Cancer Agency
Vancouver, BC
Deanna Attai, MD
University of California Los Angeles
Los Angeles, CA
Tavis Campbell, PhD*
University of Calgary
Calgary, AB 
Karen Gelmon, MD
BC Cancer Agency
Vancouver, BC
Esther Green*
Canadian Partnership Against Cancer
Toronto, ON
Lee Jones, PhD
Memorial Sloan Kettering Cancer Center
New York, NY
Steven Latosinsky, MD
Western University
London, ON
Yolanda Madarnas, MD* Kingston General Hospital
Kingston, ON
Carole Mayer, PhD*  Northeast Cancer Centre
Sudbury, ON 
Alan Nichol, MD* BC Cancer Agency
Vancouver, BC 
Susan Peterson, PhD The University of Texas MD Anderson Cancer Center
Houston, TX 
Kasmintan Schrader, MD, PhD University of British Columbia
Vancouver, BC  
Kristin L. Schreiber, MD, PhD* Brigham and Women’s Hospital
Boston, MA 
Abigail Silva, PhD*  Loyola University Chicago
Chicago, IL 
Savitri Singh-Carlson, PhD  UT Health Science Center at San Antonio
San Antonio, TX 
Ted Vandenberg, MD*  London Health Sciences Centre
London, ON 
Rebecca Auer, MD (External)  The Ottawa Hospital
Ottawa, ON 
Christine Brezden-Masley, MD (External)  St. Michael’s Hospital
Toronto, ON 
Jay Harris, MD (External)  Harvard Medical School
Boston, MA 
Andrew Karellas, PhD (External)  University of Arizona
Tuscon, AZ 
Kara Laing, MD (External)  Memorial University of Newfoundland
St. John’s, NL 
Nelson Leong, MD (Scientific Officer)  Saskatchewan Cancer Agency
Regina, SK 
* denotes reviewers who participated in the LOI Review Process only

Last modified on: September 22, 2017